Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Challenges in assessing nanomaterial toxicology: a personal perspective.

Authors
Geraci-CL; Castranova-V
Source
Wiley Interdiscip Rev. Nanomed Nanobiotechnol 2010 Nov/Dec; 2(6):569-577
NIOSHTIC No.
20037562
Abstract
Nanotechnology exploits the fact that nanoparticles exhibit unique physicochemical properties, which are distinct from fine-sized particles of the same composition. It follows that nanoparticles may also express distinct bioactivity and unique interactions with biological systems. Therefore, it is essential to assess the potential health risks of exposure to nanoparticles to allow development and implementation of prevention measures. Risk assessment requires data concerning hazard and exposure. Several challenges face the field of nanotoxicology in obtaining the necessary data for assessment of the bioactivity of nanoparticles. They include: (1) the vast number of nanoparticle types to be evaluated, (2) the need to use nanoparticle doses and structure sizes in cellular and animal test systems which are relevant to anticipated workplace exposures, and (3) artifactual in vitro results due to absorption of nutrients or assay indicator compounds from the culture media. This 'opinion' reviews the progress made in the field of nanotoxicology in recent years to overcome these challenges.
Keywords
Nanotechnology; Particulates; Risk-analysis; Exposure-assessment; Toxicology; Aerosol-particles; Airborne-particles; Health-protection; Aerosols
Contact
Vincent Castranova, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA
Publication Date
20101101
Document Type
Journal Article
Email Address
Ciu9@cdc.gov
Fiscal Year
2011
NTIS Accession No.
NTIS Price
Issue of Publication
6
ISSN
1939-5116
NIOSH Division
EID; HELD
Priority Area
Manufacturing
Source Name
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
State
OH; WV
TOP